Clinical Trial

Pain in Inflammatory Joint Diseases

Study acronym: Nor-Pain
Recruiting
View on ClinicalTrials.gov →
Summary
Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-12-02; most recent amendment 2026-04-07.
Status change: Not Yet Recruiting → Recruiting 2026-04-07
Trial Details
NCT Number NCT06718569
Lead Sponsor Diakonhjemmet Hospital
Collaborators: University of Oslo
Conditions Arthritis, Arthritis, Juvenile Idiopathic, Arthritis,Rheumatoid, Arthritis, Reactive, Arthritis, Psoriatic, Spondyloarthritis (SpA)
Enrollment 350 participants
Start Date 2025-11-11
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-04-13